Amarin is headquartered in Dublin, Ireland. In the U.S., the company's office is in Bridgewater, New Jersey. Amarin is listed in the U.S. on NASDAQ (symbol: "AMRN").
AMARIN, VASCEPA, VAZKEPA and REDUCE-IT are trademarks of Amarin Pharmaceuticals Ireland Limited. VAZKEPA is a registered trademark in Europe, the United States and other countries and regions.